YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Celgene Corp. signed on to purchase blood-disease biotechnology company Impact Biomedicines.
The deal is worth as much as $7 billion, subject to milestones related to regulatory obstacles and sales performance.
Celgene agreed to make a $1.1 billion upfront payment for the San Diego-based privately held company.
Read more from The Wall Street Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach